Literature DB >> 29458788

Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review.

Mohammad Mohajeri1, Amirhossein Sahebkar2.   

Abstract

Doxorubicin (DOX)-induced toxicity and resistance are major obstacles in chemotherapeutic approaches. Despite effective in the treatment of numerous malignancies, some clinicians have voiced concern that DOX has the potential to cause debilitating consequences in organ tissues, especially the heart. The mechanisms of toxicity and resistance are respectively related to induction of reactive oxygen species (ROS) and up-regulation of ATP-binding cassette (ABC) transporter. Curcumin (CUR) with several biological and pharmacological properties is expected to restore DOX-mediated impairments to tissues. This review is intended to address the current knowledge on DOX adverse effects and CUR protective actions in the heart, kidneys, liver, brain, and reproductive organs. Coadministration of CUR and DOX is capable of ameliorating DOX toxicity pertained to antioxidant, apoptosis, autophagy, and mitochondrial permeability.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABC transporters; Curcumin; Doxorubicin; Oxidative stress; Resistance; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 29458788     DOI: 10.1016/j.critrevonc.2017.12.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  23 in total

1.  Self-Assembled Maslinic Acid Attenuates Doxorobucin Induced Cytotoxicity via Nrf2 Signaling Pathway: An In Vitro and In Silico Study in Human Healthy Cells.

Authors:  Jhimli Banerjee; Sk Nurul Hasan; Sovan Samanta; Biplab Giri; Braja Gopal Bag; Sandeep Kumar Dash
Journal:  Cell Biochem Biophys       Date:  2022-07-18       Impact factor: 2.989

2.  Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4.

Authors:  Fangxiao Gong; Jun Jin; Hengjie Li; Hui Mao
Journal:  Cardiovasc Toxicol       Date:  2022-08-05       Impact factor: 2.755

3.  MRTF-A alleviates myocardial ischemia reperfusion injury by inhibiting the inflammatory response and inducing autophagy.

Authors:  Ze Zhong; Xiu-Ying Luo; Peng Xiang; Hong-Hui Ji; Xin-Dong Wu; Ai-Guo Chong; Xin-Yang Hu; Xiao-Lu Cao
Journal:  Mol Cell Biochem       Date:  2022-07-12       Impact factor: 3.842

4.  Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice.

Authors:  Jingang Hou; Yeejin Yun; Changhao Cui; Sunchang Kim
Journal:  Cell Prolif       Date:  2022-05-09       Impact factor: 8.755

Review 5.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Curcumin protects islet cells from glucolipotoxicity by inhibiting oxidative stress and NADPH oxidase activity both in vitro and in vivo.

Authors:  Jing Li; Ninghua Wu; Xiao Chen; Hongguang Chen; Xiaosong Yang; Chao Liu
Journal:  Islets       Date:  2019-11-21       Impact factor: 2.694

7.  Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance.

Authors:  Federica Bessone; Chiara Dianzani; Monica Argenziano; Luigi Cangemi; Rita Spagnolo; Federica Maione; Enrico Giraudo; Roberta Cavalli
Journal:  Cancer Drug Resist       Date:  2021-03-19

Review 8.  Drug Repurposing in Cancer Therapy: Influence of Patient's Genetic Background in Breast Cancer Treatment.

Authors:  Rafaela Rodrigues; Diana Duarte; Nuno Vale
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

9.  A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.

Authors:  Di Zhang; Qian Xu; Ning Wang; Yanting Yang; Jiaqi Liu; Guohua Yu; Xin Yang; Hui Xu; Hongbo Wang
Journal:  Int J Nanomedicine       Date:  2018-08-10

10.  Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects.

Authors:  Zhijun Liu; Pengyun Huang; Siukan Law; Haiyan Tian; Wingnang Leung; Chuanshan Xu
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.